EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A molecular basis underpinning TRBV28+ T-cell receptor recognition of MR1–antigen

Wael Awad, Nicholas A Gherardin, Lisa Ciacchi, Andrew N Keller, Ligong Liu, David P Fairlie, James McCluskey, Dale I Godfrey, Jamie Rossjohn

Journal of Biological Chemistry · 2025

DOI: 10.1016/j.jbc.2025.110416 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Wael Awad und 8 weiteren Autor:innen. Beteiligte Einrichtung: Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Vic…. Hauptthemen laut MEDLINE: Histocompatibility Antigens Class I, Mucosal-Associated Invariant T Cells, Receptors, Antigen, T-Cell, alpha-beta, Minor Histocompatibility Antigens. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Australian Research Council, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucosal-associated invariant T (MAIT) cells express a TRAV1-2+ T-cell receptor (TCR) that recognizes microbial vitamin B2 derivatives presented by the major histocompatibility complex class I-related molecule (MR1). Most MAIT TCRs incorporate a biased TCR-β repertoire, predominantly TRBV20-1 and TRBV6, but some utilize other trbv genes, including TRBV28. A second conserved, albeit less frequent TRAV36+ TRBV28+ T-cell population exhibits MAIT-like phenotypic features but use a markedly distinct mode of MR1-antigen (Ag) recognition compared with MAIT TCR-MR1 binding. Nevertheless, our understanding of how differing TCR gene usage results in altered MR1 binding modes remains incomplete. Here, binding studies demonstrated differential affinities and Ag specificities between TRBV6+ and TRBV28+ MR1-restricted TCRs. Alanine-scanning mutagenesis on the TRAV36-TRBV28 TCR revealed a strong dependence on germline-encoded residues within the highly selected complementarity-determining region 3α loop, similar to TRAV1-2-TRBV6 TCRs, and further alanine-scanning mutagenesis experiments demonstrate differential energetic footprints by these TCRs atop MR1. We determined the crystal structure of a MAIT TRAV1-2-TRBV28+ TCR-MR1-5-OP-RU ternary complex. This structure revealed a docking mode conserved amongst other TRAV1-2+ MAIT TCRs, with the trbv28-encoded TCR-β chain adopting highly distinct docking modes between the TRAV1-2+ and TRAV36+ TCRs. This indicates that the TCR-α chain dictates the positioning and role of the TCR-β chain. Taken together, these findings provide new molecular insights into MR1-Ag-driven selection of paired TCR-α and TCR-β chains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histocompatibility Antigens Class IMucosal-Associated Invariant T CellsReceptors, Antigen, T-Cell, alpha-betaMinor Histocompatibility AntigensHumansProtein BindingCrystallography, X-Ray

Stichwörter der Autor:innen

MAITMHC-related molecule 1TCRantigen presentationprotein structure

Substanzen

Histocompatibility Antigens Class IMR1 protein, humanReceptors, Antigen, T-Cell, alpha-betaMinor Histocompatibility Antigens

Autor:innen und Institutionen

  • Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
  • Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity at the University of Melbourne, Melbourne, Victoria, Australia.
  • Institute for Molecular Bioscience, University of Queensland, Brisbane Queensland, Australia.
  • Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity at the University of Melbourne, Melbourne, Victoria, Australia. Electronic address: godfrey@unimelb.edu.au.
  • Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia; Institute of Infection and Immunity, Cardiff Univers…

Förderung

  • NIAID NIH HHS
  • Australian Research Council
  • National Institutes of Health
  • Faculty of Information Technology, Monash University
  • National Health and Medical Research Council

Zitieren

APA

Awad, W., Gherardin, N. A., Ciacchi, L., Keller, A. N., Liu, L., Fairlie, D. P., McCluskey, J., Godfrey, D. I., & Rossjohn, J. (2025). A molecular basis underpinning TRBV28+ T-cell receptor recognition of MR1–antigen. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110416

Vancouver

Awad W, Gherardin NA, Ciacchi L, Keller AN, Liu L, Fairlie DP, et al. A molecular basis underpinning TRBV28+ T-cell receptor recognition of MR1–antigen. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110416

BibTeX
@article{Awad2025,
  author = {Awad, Wael and Gherardin, Nicholas A and Ciacchi, Lisa and Keller, Andrew N and Liu, Ligong and Fairlie, David P and McCluskey, James and Godfrey, Dale I and Rossjohn, Jamie},
  title = {A molecular basis underpinning TRBV28+ T-cell receptor recognition of MR1–antigen},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2025.110416}
}
Kostenlos starten →